Recent Updates
Recently added Catalysts
BBIO Positive Sentiment Score: 75/100

BridgeBio Pharma to Participate in the 45th Annual Goldman Sachs Global Healthcare Conference

Thursday, June 6, 2024 1 min read
Key Takeaway: BridgeBio Pharma will present at the 45th Annual Goldman Sachs Global Healthcare Conference on June 12, 2024. CEO Neil Kumar will represent the company during this esteemed event held in Miami, FL. Investors can access a live webcast of the presentation, which will also be available for replay for 90 days post-event.

Market Sentiment Analysis

POSITIVE FACTORS

  • BridgeBio is participating in a prestigious annual conference.
  • The CEO will present, showcasing the company's advancements.
  • The event provides an opportunity for investor engagement.

Full Press Release Details

PALO ALTO, Calif., June 06, 2024 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a commercial-stage biopharmaceutical company focused on genetic diseases and cancers, today announced that Neil Kumar, Ph.D., founder and CEO of BridgeBio, will present at the Goldman Sachs Annual Global Healthcare Conference in Miami, FL on Wednesday, June 12 at 3:20 pm EDT.
To access the live webcast of BridgeBio’s presentation, please visit the “Events & Presentations” page within the Investors section of the BridgeBio website at http://investor.bridgebio.com. A replay of the webcast will be available on the BridgeBio website for 90 days following the event.
About BridgeBio Pharma, Inc.
contact@bridgebio.com

Frequently Asked Questions

When will Neil Kumar present at the Goldman Sachs conference?

Neil Kumar will present on June 12 at 3:20 pm EDT.

Where can I watch the live webcast of the presentation?

The live webcast can be accessed on the BridgeBio Investors page.

How long will the webcast replay be available?

The replay will be available for 90 days after the event.

What is BridgeBio Pharma focused on?

BridgeBio Pharma focuses on genetic diseases and cancers.

Tags: BBIO Viatris Investor Conferences Healthcare BridgeBio Goldman Sachs healthcare conference biopharmaceutical genetic diseases
Last updated: Jun 6, 2024